- Report
- March 2024
- 194 Pages
Global
From €3216EUR$3,374USD£2,759GBP
€3573EUR$3,749USD£3,065GBP
- Report
- August 2022
- 120 Pages
Global
From €2383EUR$2,500USD£2,044GBP
- Report
- October 2023
- 96 Pages
Global
From €3500EUR$3,934USD£3,107GBP
- Report
- May 2024
- 50 Pages
Global
From €2526EUR$2,650USD£2,167GBP
- Report
- May 2024
- 50 Pages
Global
From €2526EUR$2,650USD£2,167GBP
- Report
- May 2024
- 50 Pages
Global
From €2526EUR$2,650USD£2,167GBP
- Report
- March 2022
Global
From €4623EUR$4,850USD£3,965GBP
- Report
- March 2021
Japan, United States, ... Japan, United States, Europe
From €905EUR$950USD£777GBP
- Report
- February 2020
Japan, United States, ... Japan, United States, Europe
From €905EUR$950USD£777GBP
Quinidine is a medication used to treat irregular heartbeats, or arrhythmias. It is a type of antiarrhythmic drug, which works by blocking certain electrical signals in the heart that cause arrhythmias. Quinidine is used to treat atrial fibrillation, atrial flutter, and ventricular tachycardia. It is also used to treat certain types of supraventricular tachycardia, such as Wolff-Parkinson-White syndrome. Quinidine is available in both oral and injectable forms.
Quinidine is a part of the larger cardiovascular drug market, which includes medications used to treat a variety of heart conditions. These drugs are used to treat high blood pressure, heart failure, and coronary artery disease, as well as arrhythmias. The cardiovascular drug market is highly competitive, with many different companies offering a variety of medications.
Some of the companies in the quinidine market include Pfizer, Merck, GlaxoSmithKline, and Sanofi. These companies offer both generic and branded versions of quinidine, as well as other antiarrhythmic drugs. Show Less Read more